Mass. fires head of board overseeing compounding pharmacies

NewsGuard 100/100 Score

Officials say James Coffey did not investigate a complaint from Colorado about the center now tied to the meningitis outbreak.

The Wall Street Journal: Pharmacy Board Head Fired Over Meningitis
Massachusetts' health department said Wednesday that it has fired the director of its pharmacy board, after he failed earlier this year to investigate a complaint about the drug-mixing pharmacy recently implicated in a deadly meningitis outbreak. James Coffey, director of the Massachusetts Board of Pharmacy, failed to follow up on a complaint from the Colorado pharmacy board accusing New England Compounding Center of illegally selling medicines without a prescription, the Massachusetts health department said in a statement (Rockoff, 11/7).

Reuters:  Massachusetts Pharmacy Board Head Fired After Meningitis Outbreak
Authorities fired the director of the Massachusetts Board of Pharmacy after he failed to investigate a complaint against New England Compounding Center, the company at the center of a deadly U.S. meningitis outbreak, state officials said on Wednesday. NECC is linked to a meningitis outbreak that has infected more than 400 people and caused 31 deaths. ... Coffey was not immediately available for comment (McLaughlin, 11/7).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New study shows how brain glucose affects fungal disease treatment